Showing results (1571-1580 of 1,781) with videos related to

Sort By:
Pageof 179
Hepatobiliary Surgery and Nutrition|October 27, 2023
Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individualsWen Hui Lim, Snow Yunni Lin, Cheng Han Ng, et al.
Eclinicalmedicine|October 4, 2022
The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysisYip Han Chin, Cheng Han Ng, Nicholas Ws Chew, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|April 30, 2022
[Course of disease and related epidemiological parameters of COVID-19: a prospective study based on contact tracing cohort]Y Zhou, W J Liang, Z H Chen, et al.
Hepatology Communications|November 9, 2020
ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data ValidationDaniel Q Huang, Yee Hui Yeo, Eunice Tan, et al.
Lancet (London, England)|February 6, 2022
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trialDavid M Gershenson, Austin Miller, William E Brady, et al.
Alimentary Pharmacology & Therapeutics|January 30, 2023
The prognostic value of including non-alcoholic fatty liver disease in the definition of metabolic syndromeClarissa Elysia Fu, Jie Ning Yong, Cheng Han Ng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2024
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005Jung-Min Lee, Mark F Brady, Austin Miller, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2020
Comparative biomarkers for HBsAg loss with antiviral therapy shows dominant influence of quantitative HBsAg (qHBsAg)Seng Gee Lim, Wah Wah Phyo, Joanna Zhi Jie Ling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology StudyLarry J Copeland, Mark F Brady, Robert A Burger, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|July 12, 2018
[Efficacy and safety of paritaprevir/ritonavir/ombitasvir combined with dasabuvir in non-cirrhotic Asian adult patients with newly diagnosed and treated chronic HCV genotype 1b infection: a randomized, double-blind, placebo-controlled study - China data]L Wei, J Cheng, J Luo, et al.
Pageof 179